Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  HIV Infection

  Free Subscription


1 BMC Cancer
3 Clin Infect Dis
3 HIV Med
3 Int J Cancer
8 J Acquir Immune Defic Syndr
1 J Clin Invest
1 J Immunol
2 J Infect Dis
2 J Virol
1 Lancet Infect Dis
1 Nat Med
1 PLoS Med
9 PLoS One
1 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. DAVEY DLJ, Nyemba DC, Mvududu R, Mashele N, et al
    Pregnancy outcomes following self-reported and objective-measured exposure to oral preexposure prophylaxis in South Africa: an observational cohort study.
    AIDS. 2023 Sep 18. doi: 10.1097/QAD.0000000000003729.
    PubMed         Abstract available

  2. SLOGROVE AL, Bovu A, de Beer S, Phelanyane F, et al
    Maternal and birth outcomes in pregnant people with and without HIV in the Western Cape, South Africa: population-based cohort study.
    AIDS. 2023 Sep 15. doi: 10.1097/QAD.0000000000003728.
    PubMed         Abstract available

    BMC Cancer

  3. AKANBI MO, Bilaver LA, Achenbach C, Hirschhorn LR, et al
    Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.
    BMC Cancer. 2023;23:890.
    PubMed         Abstract available


  4. MOHRAZ M, Vahdat K, Ghamari SH, Abbasi-Kangevari M, et al
    Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial.
    BMJ. 2023;382:e070464.
    PubMed         Abstract available

    Clin Infect Dis

  5. ASTURIAS EJ, Excler JL, Ackland J, Cavaleri M, et al
    Safety of Streptococcus pyogenes vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post Marketing Monitoring.
    Clin Infect Dis. 2023 May 26:ciad311. doi: 10.1093.
    PubMed         Abstract available

  6. ROMANOWSKI K, Law MR, Karim ME, Campbell JR, et al
    Healthcare utilization after respiratory tuberculosis: a controlled interrupted time series analysis.
    Clin Infect Dis. 2023 May 9:ciad290. doi: 10.1093.
    PubMed         Abstract available

  7. MEYEROWITZ EA, Mukerji SS, Kyle Harrold G, Erdil RM, et al
    Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based Series.
    Clin Infect Dis. 2023;77:851-856.
    PubMed         Abstract available

    HIV Med

  8. LUI GC, Wong GL, Yang HC, Sheng WH, et al
    Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia.
    HIV Med. 2023 Sep 21. doi: 10.1111/hiv.13545.
    PubMed         Abstract available

  9. SONDERGAARD MH, Thavarajah JJ, Churchill Henson H, Wejse CM, et al
    SARS-CoV-2 vaccine immunogenicity for people living with HIV: A systematic review and meta-analysis.
    HIV Med. 2023 Sep 21. doi: 10.1111/hiv.13537.
    PubMed         Abstract available

  10. ELEN S, Bjorkman P, Zazzi M, Bohm M, et al
    Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression.
    HIV Med. 2023 Sep 18. doi: 10.1111/hiv.13541.
    PubMed         Abstract available

    Int J Cancer

  11. ENGELS EA, Shiels MS, Barnabas RV, Bohlius J, et al
    State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34727.
    PubMed         Abstract available

  12. MUNGO C, Osongo CO, Ambaka J, Omoto J, et al
    Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34737.
    PubMed         Abstract available

  13. LIU Y, Bhardwaj S, Sigel K, Winters J, et al
    Anal cancer screening results from 18-to-34-year-old men who have sex with men living with HIV.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34734.
    PubMed         Abstract available

    J Acquir Immune Defic Syndr

  14. TURPIN RE, Mandell CJ, Camp AD, Davidson Mhonde RR, et al
    Covid-19, Vaccine Hesitancy, and HIV pre-exposure prophylaxis among Black sexual minority men.
    J Acquir Immune Defic Syndr. 2023 Sep 15. doi: 10.1097/QAI.0000000000003305.
    PubMed         Abstract available

  15. TAHA TE, Bandala-Jacques A, Yende-Zuma N, Violari A, et al
    Breastfeeding Among Women living with HIV in the Era of Lifelong ART: An Observational Multi-Country Study in Eastern and Southern Africa.
    J Acquir Immune Defic Syndr. 2023 Sep 15. doi: 10.1097/QAI.0000000000003306.
    PubMed         Abstract available

  16. N C, L H, Wdf V, S S, et al
    National impact of SARS-CoV-2 infection on HIV virological suppression in South Africa.
    J Acquir Immune Defic Syndr. 2023 Sep 19. doi: 10.1097/QAI.0000000000003307.
    PubMed         Abstract available

  17. MCCOLLUM CG, Carodine A, Chiedo A, Penney B, et al
    Social Support Assets and Needs of Underrepresented Students Participating in Health Sciences Pathways Programs in Birmingham, Alabama.
    J Acquir Immune Defic Syndr. 2023;94.
    PubMed         Abstract available

  18. ROBINSON SA, Menezes P, Zinck M, McCrimmon J, et al
    An Internship Approach to Strengthen the Pathway for Historically Underrepresented Groups in Health Sciences Research: The North Carolina Diversity and Inclusion Pathway Program.
    J Acquir Immune Defic Syndr. 2023;94.
    PubMed         Abstract available

  19. ANTOINE DG, Manogue S, Blue J, Irvin R, et al
    Addressing Stigma by Increasing Empathy Toward Vulnerable Populations in Preprofessional Trainees: Impacts of the Generation Tomorrow Summer Health Disparities Scholars Program.
    J Acquir Immune Defic Syndr. 2023;94.
    PubMed         Abstract available

  20. GREENBERG AE, Wutoh AK, Bowleg L, Magnus M, et al
    Supplemental Issue of the Journal of the Acquired Immune Deficiency Syndromes (JAIDS): The Centers for AIDS Research (CFAR) Diversity, Equity, and Inclusion Pathway Initiative (CDEIPI).
    J Acquir Immune Defic Syndr. 2023;94.

  21. PARIKH UM, Penrose KJ, Heaps AL, Sethi R, et al
    HIV Drug Resistance Assessment among Women who Seroconverted during the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial.
    J Acquir Immune Defic Syndr. 2023 Sep 20. doi: 10.1097/QAI.0000000000003308.
    PubMed         Abstract available

    J Clin Invest

  22. WIETGREFE SW, Anderson J, Duan L, Southern PJ, et al
    Initial productive and latent HIV infections originate in vivo by infection of resting T cells.
    J Clin Invest. 2023 Sep 21:e171501. doi: 10.1172/JCI171501.
    PubMed         Abstract available

    J Immunol

  23. KAUR A, Surnilla A, Zaitouna AJ, Mumphrey MB, et al
    Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing.
    J Immunol. 2023 Sep 22:ji2300232. doi: 10.4049/jimmunol.2300232.
    PubMed         Abstract available

    J Infect Dis

  24. SALYARDS M, Nijhawan AE, Kuo J, Knights SM, et al
    Prevalence, Incidence, and Predictors of Kaposi Sarcoma-associated Herpesvirus Infection Among Young Men Who Have Sex with Men in the Southern United States.
    J Infect Dis. 2023 Sep 15:jiad384. doi: 10.1093.
    PubMed         Abstract available

  25. VAN DE WEG CAM, Thomazella MV, Marmorato MP, Correia CA, et al
    Levels of angiopoietin-2 are predictive for mortality in yellow fever virus infected patients.
    J Infect Dis. 2023 Sep 15:jiad389. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  26. OGUNDIRAN AI, Chang TL, Ivanov A, Kumari N, et al
    Shear-reversible clusters of HIV-1 in solution: stabilized by antibodies, dispersed by mucin.
    J Virol. 2023 Sep 15:e0075223. doi: 10.1128/jvi.00752.
    PubMed         Abstract available

  27. KRCHLIKOVA V, Lotke R, Haussmann I, Reinisova M, et al
    Independent loss events of a functional tetherin gene in galliform birds.
    J Virol. 2023 Sep 15:e0080323. doi: 10.1128/jvi.00803.
    PubMed         Abstract available

    Lancet Infect Dis

  28. URIU K, Ito J, Kosugi Y, Tanaka YL, et al
    Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant.
    Lancet Infect Dis. 2023 Sep 18:S1473-3099(23)00575.

    Nat Med

  29. BRANCHE AR, Rouphael NG, Diemert DJ, Falsey AR, et al
    Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
    Nat Med. 2023 Aug 28. doi: 10.1038/s41591-023-02503.
    PubMed         Abstract available

    PLoS Med

  30. INZAULE SC, Siedner MJ, Little SJ, Avila-Rios S, et al
    Recommendations on data sharing in HIV drug resistance research.
    PLoS Med. 2023;20:e1004293.
    PubMed         Abstract available

    PLoS One

  31. TEKESE D, Dawit D, Hawulte B, Mohammed H, et al
    Incidence and predictors of tuberculosis among children receiving antiretroviral therapy in the Wolaita Zone: A retrospective cohort study.
    PLoS One. 2023;18:e0291502.
    PubMed         Abstract available

  32. ASSEFA MG, Deksisa A, Abdo M, Alemayehu OT, et al
    Predictors of underweight among adult patients receiving antiretroviral therapy in Bishoftu general hospital, central Ethiopia: Case-control study.
    PLoS One. 2023;18:e0291602.
    PubMed         Abstract available

  33. YANG M, Li C, Zou K, Liang Y, et al
    "They have their own people": Emotional connections, community belonging, and Chinese gay, bisexual and other men who have sex with men (GBMSM) college students' needs for sexual health support.
    PLoS One. 2023;18:e0291550.
    PubMed         Abstract available

  34. ABDULAI M, Owiredu D, Boadu I, Tabong PT, et al
    Psychosocial interventions and their effectiveness on quality of life among elderly persons living with HIV in Africa South of the Sahara: Systematic review and meta -analysis protocol.
    PLoS One. 2023;18:e0291781.
    PubMed         Abstract available

  35. OSEI E, Amu H, Kye-Duodu G, Kwabla MP, et al
    Impact of COVID-19 pandemic on Tuberculosis and HIV services in Ghana: An interrupted time series analysis.
    PLoS One. 2023;18:e0291808.
    PubMed         Abstract available

  36. KYILYOSUDU H, Msuya SE, Ngocho JS, Damian DJ, et al
    Factors associated with offer and uptake of provider-initiated HIV testing and counselling among men attending healthcare facilities in Moshi Municipality, Northern Tanzania.
    PLoS One. 2023;18:e0291792.
    PubMed         Abstract available

  37. KAUL CM, Moore BE, Kaplan-Lewis E, Casey E, et al
    EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP).
    PLoS One. 2023;18:e0291657.
    PubMed         Abstract available

  38. GANT Z, Dailey A, Hu X, Song W, et al
    The associations of income and Black-White racial segregation with HIV outcomes among adults aged >/=18 years-United States and Puerto Rico, 2019.
    PLoS One. 2023;18:e0291304.
    PubMed         Abstract available

  39. JIN H, Tappenden P, Ling X, Robinson S, et al
    A systematic review of whole disease models for informing healthcare resource allocation decisions.
    PLoS One. 2023;18:e0291366.
    PubMed         Abstract available


  40. REID MC, Mittler JE, Murphy JT, Stansfield SE, et al
    Evolution of HIV virulence in response to disease-modifying vaccines: A modeling study.
    Vaccine. 2023 Sep 13:S0264-410X(23)01027-7. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.